TY - JOUR
T1 - Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy - Surgical Technique, Post-Operative Care, Expected Outcomes and Retreatment/Enhancements
AU - Grippo, Tomas M.
AU - Töteberg-Harms, Marc
AU - Giovingo, Michael
AU - Francis, Brian A.
AU - de Crom, Ronald R.M.P.C.
AU - Jerkins, Brian
AU - Brubaker, Jacob W.
AU - An, Jella
AU - Radcliffe, Nathan
AU - Noecker, Robert
N1 - Publisher Copyright:
© 2023 Grippo et al.
PY - 2023
Y1 - 2023
N2 - Purpose: To provide expert consensus and evidence-based current guidelines on treatment technique, postoperative care, expected outcomes and retreatment for MicroPulse Transscleral Laser Treatment (TLT). Methods: A comprehensive search of PubMed led to the identification and analysis of 61 studies on MicroPulse TLT. To provide guidance in areas where there was not enough available literature, a three-round Delphi method was conducted involving 10 international experts in MicroPulse TLT. Results: The response rate was 70% in the first round, 70% in the second round, and 80% in the third round of the Delphi method. Once all responses were aggregated, a live meeting was held with 90% attendance, and consensus was achieved on each of the findings detailed in this manuscript. Conclusion: Used within appropriate treatment parameters, with proper technique and patient selection, MicroPulse TLT is a safe and effective treatment for many types and severities of glaucoma. MicroPulse TLT represents a useful addition to the glaucoma armamentarium.
AB - Purpose: To provide expert consensus and evidence-based current guidelines on treatment technique, postoperative care, expected outcomes and retreatment for MicroPulse Transscleral Laser Treatment (TLT). Methods: A comprehensive search of PubMed led to the identification and analysis of 61 studies on MicroPulse TLT. To provide guidance in areas where there was not enough available literature, a three-round Delphi method was conducted involving 10 international experts in MicroPulse TLT. Results: The response rate was 70% in the first round, 70% in the second round, and 80% in the third round of the Delphi method. Once all responses were aggregated, a live meeting was held with 90% attendance, and consensus was achieved on each of the findings detailed in this manuscript. Conclusion: Used within appropriate treatment parameters, with proper technique and patient selection, MicroPulse TLT is a safe and effective treatment for many types and severities of glaucoma. MicroPulse TLT represents a useful addition to the glaucoma armamentarium.
KW - MicroPulse
KW - glaucoma
KW - transscleral laser treatment
UR - http://www.scopus.com/inward/record.url?scp=85146165214&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85146165214&partnerID=8YFLogxK
U2 - 10.2147/OPTH.S389198
DO - 10.2147/OPTH.S389198
M3 - Article
C2 - 36636622
AN - SCOPUS:85146165214
SN - 1177-5467
VL - 17
SP - 71
EP - 83
JO - Clinical Ophthalmology
JF - Clinical Ophthalmology
ER -